# SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

> **NCT03626948** · PHASE3 · COMPLETED · sponsor: **Sanwa Kagaku Kenkyusho Co., Ltd.** · enrollment: 157 (actual)

## Conditions studied

- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** SK-1403

## Key facts

- **NCT ID:** NCT03626948
- **Lead sponsor:** Sanwa Kagaku Kenkyusho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-13
- **Primary completion:** 2020-02-04
- **Final completion:** 2020-02-05
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03626948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03626948, "SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03626948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*